missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human LGI2 Synthetic Peptide
Click to view available options
Quantity:
50 μg
missing translation for 'unitSize'
50µg
Beschreibung
LGI2 Synthetic Peptide, PEP-0613, from Invitrogen.
The leucine-rich, glioma inactivated gene 2 (LGI2) is a member of the LGI family in which LGI1 is the exemplar. The LGI family consists of four of highly related proteins containing leucine-rich repeats (LRRs) which are highly similar to other transmembrane signaling molecules and receptors. LGI1 has been identified as a candidate tumor suppressor gene for glioma and plays a role in autodominant lateral temporal epilepsy (ADTLE), an epileptic syndrome characterized by focal seizures with predominant auditory symptoms. Despite its high homology with LGI1 and similar pattern of expression, mutations in LGI2 have not been found to be associated with ADTLE.
Spezifikation
Spezifikation
| Gene ID (Entrez) | 55203 |
| Species | Human |
| Purification Method | purified |
| Accession Number | Q8N0V4 |
| Common Name | Human LGI2 |
| Concentration | 200 μg/mL |
| Content And Storage | -20°C |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formulation | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| Mehr anzeigen |
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur